Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
July 8, 2016
A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma
Jin-Qing Liu, Fatemeh Talebian, Lisha Wu, et al.
Journal of Surgical Oncology
|
August 23, 2018
Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma
Nicholas Latchana, Mallory J DiVincenzo, Kelly Regan, et al.
Protein Science : a Publication of the Protein Society
|
March 8, 2016
Structural characterization of NRAS isoform 5
Joseph Markowitz, Tapas K Mal, Chunhua Yuan, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
spatialGE: A user-friendly web application to democratize spatial transcriptomics analysis
Oscar E Ospina, Roberto Manjarres-Betancur, Guillermo Gonzalez-Calderon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 20, 2015
MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies
Malori A Lankenau, Ravi Patel, Sandya Liyanarachchi, et al.
Cancer Immunology, Immunotherapy : CII
|
February 12, 2026
First-line ipilimumab plus nivolumab in advanced merkel cell carcinoma: a meta-analysis of prospective trials and real-world validation cohort
Tanya Ramadoss, Christian Palacios, Matthew Nichols, et al.
World Journal of Surgery
|
December 8, 2019
Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy
James Sun, Dennis A Kirichenko, Joyce L Chung, et al.
Journal for Immunotherapy of Cancer
|
September 6, 2024
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma
Tanya Ramadoss, Matthew Nichols, Christian Palacios, et al.
Cancer Immunology, Immunotherapy : CII
|
October 12, 2014
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease
Joseph Markowitz, Taylor R Brooks, Megan C Duggan, et al.
Pigment Cell & Melanoma Research
|
July 23, 2019
Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma
Zeynep Eroglu, Jennifer Eatrides, Syeda Mahrukh Hussnain Naqvi, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Journal of Immunology (Baltimore, Md. : 1950)
|
July 8, 2016
A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma
Jin-Qing Liu, Fatemeh Talebian, Lisha Wu, et al.
Journal of Surgical Oncology
|
August 23, 2018
Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma
Nicholas Latchana, Mallory J DiVincenzo, Kelly Regan, et al.
Protein Science : a Publication of the Protein Society
|
March 8, 2016
Structural characterization of NRAS isoform 5
Joseph Markowitz, Tapas K Mal, Chunhua Yuan, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
spatialGE: A user-friendly web application to democratize spatial transcriptomics analysis
Oscar E Ospina, Roberto Manjarres-Betancur, Guillermo Gonzalez-Calderon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 20, 2015
MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies
Malori A Lankenau, Ravi Patel, Sandya Liyanarachchi, et al.
Cancer Immunology, Immunotherapy : CII
|
February 12, 2026
First-line ipilimumab plus nivolumab in advanced merkel cell carcinoma: a meta-analysis of prospective trials and real-world validation cohort
Tanya Ramadoss, Christian Palacios, Matthew Nichols, et al.
World Journal of Surgery
|
December 8, 2019
Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy
James Sun, Dennis A Kirichenko, Joyce L Chung, et al.
Journal for Immunotherapy of Cancer
|
September 6, 2024
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma
Tanya Ramadoss, Matthew Nichols, Christian Palacios, et al.
Cancer Immunology, Immunotherapy : CII
|
October 12, 2014
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease
Joseph Markowitz, Taylor R Brooks, Megan C Duggan, et al.
Pigment Cell & Melanoma Research
|
July 23, 2019
Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma
Zeynep Eroglu, Jennifer Eatrides, Syeda Mahrukh Hussnain Naqvi, et al.
Page
of 9